Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1990-11-13
1993-03-16
Lacey, David L.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
5303875, 5303888, 435 7021, 4351722, C12N 520, C12N 1502, C07K 1528, C12P 2108
Patent
active
051943859
ABSTRACT:
The present invention relates to a monoclonal antibody MLS 102 recognizing human intestinal cancer cells, especially their sugar chain of glycoprotein, and more specifically NeuAc .alpha.2.fwdarw.6GalNAc. The invention also relates to a hybridoma producing the monoclonal antibody which is prepared by fusing splenic cells of a mouse immunized by human intestinal cancer cells with myeloma cells.
REFERENCES:
Johnson, V. G. et al. "Analysis of a Human Tumor-Associated Glycoprotein (TAG-72) Identified by Monoclonal Antibody B72.3", Cancer Research 46:850-857, Feb. 1986.
Colcher, D. et al. "A Spectrum of Monoclonal Antibodies Reactive with Human Mammary Tumor Cells," Proc. Nat'l. Acad. Sci. 78(5):3199-3203, May 1981.
Kurosaka, A. et al. "Mucin-Carbohydrate Directed Monoclonal Antibody," FEBS Letters 215(1):137-139, May 1987.
Nudelman, E. et al. "Novel Fucolipids of Human Adenocarcinoma. Disialosyl Le.sup.a Antigen (III.sup.4 Fuc III.sup.6 NeuAcIV.sup.3 NeuAcLc.sub.4) of Human Colonic Adenocarcinoma and the Monoclonal Antibody (FH7) Defining This Structure," J. Biol. Chem. 261(12):5487-5495, Apr. 25, 1986.
Gottschalk, A. et al. "Submaxillary Gland Glycoproteins," In: Glycoproteins, Gottschalk, A. (ed.), Elsevier, Amsterdam, New York, 1972, pp. 810-829.
Kannagi et al. in Weir et al. Eds. "Handbook of Exptl. Immunol." vol. 4, Blackwell Sci Publ., May 30, 1986.
Giraldo et al, "From Oncogenes to Tumor Antigens" Elsevier Sci. Publ. 1985.
Kurosaka et al., J. Biol. Chem 263:8724-8776, 1988.
The Journal of Biological Chemistry, Nakada et al., vol. 266, No. 19, pp. 12402-12405, 1991.
Hutzell Paula
Lacey David L.
Shionogi & Co. Ltd.
LandOfFree
Hybridoma and monoclonal antibody MLS102 which recognizes a NeuA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridoma and monoclonal antibody MLS102 which recognizes a NeuA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma and monoclonal antibody MLS102 which recognizes a NeuA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-350425